Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.86 CHF | -0.17% |
|
-1.51% | +70.35% |
Jun. 20 | Top Premarket Gainers | MT |
Jun. 17 | Transcript : Molecular Partners AG Presents at TD Cowen 2nd Annual Radiopharmaceutical Innovation Summit, Jun-17-2024 10:40 AM |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+70.35% | 218M | |
+21.55% | 127B | |
+24.85% | 117B | |
+26.35% | 27.67B | |
-18.83% | 20.33B | |
-15.59% | 16.79B | |
-17.91% | 15.63B | |
+13.35% | 14.84B | |
-47.70% | 14.65B | |
+56.85% | 14.43B |
- Stock Market
- Equities
- MOLN Stock
- News Molecular Partners AG
- Molecular Partners Gears Up for 2024 Milestones, Including Data From Leukemia Treatment Trial